InsidersTradesSigma
Track the Sionna Therapeutics, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €266.8m. The latest transaction was reported on 9 July 2026 (Cession). Among the most active insiders: Booth Bruce. The full history is accessible without an account.
65
Insider Decl.
n/a
Thresholds
€812,849
1 ops.
Buy Volume
€77m
47 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sionna Therapeutics, Inc. Hold (neutral), based on 6 analysts. Average price target: US$15.17.
57Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 July 2026
Declarations65 total
85,918 shares@ US$44.861.47% mcap13.5% of flowCommon StockSEC:0000947871-26-000694:0
85,918 shares@ US$44.861.47% mcap13.5% of flowCommon StockSEC:0000947871-26-000695:0
10,250 shares@ US$6.110.024% mcap12.3% of flowCommon StockSEC:0002061851-26-000006:0
10,250 shares@ US$43.59630.17% mcap87.7% of flowCommon StockSEC:0002061851-26-000006:1
10,250 shares@ US$43.990.17% mcap100.0% of flowCommonSEC144:0001950047-26-006887
52,397 shares@ US$44.680.87% mcap9.2% of flowCommon StockSEC:0000947871-26-000458:0
2,948 shares@ US$44.520.049% mcap0.5% of flowCommon StockSEC:0000947871-26-000458:1
52,397 shares@ US$44.680.87% mcap9.2% of flowCommon StockSEC:0000947871-26-000459:0
2,948 shares@ US$44.520.049% mcap0.5% of flowCommon StockSEC:0000947871-26-000459:1
47,814 shares@ US$44.510.79% mcap8.4% of flowCommon StockSEC:0000947871-26-000446:0
235,863 shares@ US$44.643.90% mcap41.4% of flowCommon StockSEC:0000947871-26-000446:1
226,906 shares@ US$45.343.82% mcap40.5% of flowCommon StockSEC:0000947871-26-000446:2
47,814 shares@ US$44.510.79% mcap8.4% of flowCommon StockSEC:0000947871-26-000447:0
235,863 shares@ US$44.643.90% mcap41.4% of flowCommon StockSEC:0000947871-26-000447:1
226,906 shares@ US$45.343.82% mcap40.5% of flowCommon StockSEC:0000947871-26-000447:2
10,250 shares@ US$6.118.9% of flowCommon StockSEC:0002061851-26-000004:0
1,890 shares@ US$44.570.2% of flowCommon StockSEC:0000947871-26-000088:0
1,890 shares@ US$44.570.2% of flowCommon StockSEC:0000947871-26-000089:0
250,000 shares@ US$40.0091.3% of flowCommon StockSEC:0001999371-26-001696:0
33,356 shares@ US$44.554.2% of flowCommon StockSEC:0000947871-25-001095:0
33,356 shares@ US$44.554.2% of flowCommon StockSEC:0000947871-25-001096:0
900 shares@ US$44.500.1% of flowCommon StockSEC:0000947871-25-001088:0
900 shares@ US$44.500.1% of flowCommon StockSEC:0000947871-25-001087:0
10,250 shares@ US$6.119.7% of flowCommon StockSEC:0002061851-25-000003:0
94,583 shares@ US$44.5412.8% of flowCommon StockSEC:0000947871-25-001045:0
25 of 65 declarations
关于 Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. 是一家专注于开发创新疗法以治疗神经系统疾病的公司。该公司在 XNAS 市场上市。